Περίληψη:
In a previous paper, as the first of a series of three on the importance of characteristics and modalities of physical activity (PA) and exercise in the management of cardiovascular health within the general population, we concluded that, in the population at large, PA and aerobic exercise capacity clearly are inversely associated with increased cardiovascular disease risk and all-cause and cardiovascular mortality and that a dose-response curve on cardiovascular outcome has been demonstrated in most studies. More and more evidence is accumulated that engaging in regular PA and exercise interventions are essential components for reducing the severity of cardiovascular risk factors, such as obesity and abdominal fat, high BP, metabolic risk factors, and systemic inflammation. However, it is less clear whether and which type of PA and exercise intervention (aerobic exercise, dynamic resistive exercise, or both) or characteristic of exercise (frequency, intensity, time or duration, and volume) would yield more benefit for each separate risk factor. The present paper, therefore, will review and make recommendations for PA and exercise training in the management of cardiovascular health in individuals with cardiovascular risk factors. The guidance offered in this series of papers is aimed at medical doctors, health practitioners, kinesiologists, physiotherapists and exercise physiologists, politicians, public health policy makers, and individual members of the public. Based on previous and the current literature overviews, recommendations from the European Association on Cardiovascular Prevention and Rehabilitation are formulated regarding type, volume, and intensity of PA and regarding appropriate risk evaluation during exercise in individuals with cardiovascular risk factors. © 2011 The European Society of Cardiology.
Συγγραφείς:
Vanhees, L.
Geladas, N.
Hansen, D.
Kouidi, E.
Niebauer, J.
Reiner, Z.
Cornelissen, V.
Adamopoulos, S.
Prescott, E.
Börjesson, M.
Λέξεις-κλειδιά:
apolipoprotein A1; apolipoprotein A2; apolipoprotein C2; apolipoprotein C3; beta adrenergic receptor blocking agent; C reactive protein; glucose; glycosylated hemoglobin; hemoglobin A1c; high density lipoprotein cholesterol; insulin; interleukin 1 receptor blocking agent; interleukin 10; interleukin 1beta; interleukin 6; interleukin 8; lactic acid; low density lipoprotein cholesterol; rosiglitazone; triacylglycerol, aerobic exercise; anaerobic threshold; anxiety disorder; artery compliance; blood glucose monitoring; blood pressure regulation; body composition; body mass; body weight; cardiovascular risk; cholesterol blood level; cytokine production; cytokine response; depression; endurance training; energy expenditure; exercise intensity; fibrinogen blood level; follow up; glucose blood level; glucose metabolism; health care personnel; health care policy; heart rate variability; hemoglobin blood level; hemostasis; human; hypertriglyceridemia; impaired glucose tolerance; inflammation; insulin blood level; insulin resistance; isokinetic exercise; lactate blood level; lifestyle modification; meta analysis (topic); metabolic equivalent; muscle isometric contraction; non insulin dependent diabetes mellitus; obesity; particle size; patient care; patient counseling; patient referral; patient safety; physical activity; physiotherapist; plyometrics; prescription; priority journal; public health service; randomized controlled trial (topic); resistance training; review; sport; triacylglycerol blood level; weight control; weight lifting; weight reduction; cardiovascular disease; daily life activity; exercise; kinesiotherapy; obesity; physiology; practice guideline; public health; risk factor; standard, Activities of Daily Living; Cardiovascular Diseases; Exercise; Exercise Therapy; Humans; Obesity; Practice Guidelines as Topic; Public Health; Risk Factors
